Skip to Main Content
Contact Us
Helping to bring cancer therapies to patients  Niche CRO with a difference Catalyst Oncology is a niche oncology CRO devoting time, energy, Read Now Expanding Clinical Trial Diversity: A Catalyst Values Approach “Today, overall cancer clinical trial enrollment in the United States is 8% (6.3%‐7.0% at community Read Now Helping to Bring Immunotherapies to Cancer Patients in Need Catalyst Oncology is a specialty oncology clinical research organization (CRO) devoting time, energy, and capital Read Now Automation of Exploratory Report Generation Using R Shiny and R Markdown Exploratory data analysis (EDA) in clinical research involves analyzing and summarizing data to extract insights, Read Now Enhancing the Data Journey in Oncology Clinical Trials Clinical trials are the springboard for progress in modern healthcare, guiding the development and evaluation Read Now Highlights of ESMO 2023: The year of ADCs Insights from the annual oncology conference By Andrew Zupnick, PhD, Vice President of Oncology Drug Read Now Catalyst Clinical Research Honored for Innovative Use of AI Catalyst Accepts Award for Our Support of Drug Development Recognition from Medidata for support of Read Now Catalyst Clinical Research Named One of Fastest Growing Companies Catalyst Ranks in Top of Annual List For fourth consecutive year, CRO recognized for its Read Now Medidata Announces Multi-Year Partnership Expansion with Catalyst for Oncology Trial Delivery Expanded Collaboration Continues to Deliver for CRO and Its Clients Ongoing collaboration demonstrates Medidata’s expertise Read Now Agile Protocol Development Medical Writing Services Help Achieve Client’s Goal Pharmaceutical companies are increasingly seeking new avenues to Read Now